2015-2025 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Research by Type, End-Use and Region

July 2024 | 100 pages | ID: 29A481841462EN
99Strategy

Abstracts

SUMMARY

The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Transposagen Biopharmaceuticals
• Sutro Biopharma
• Malin Corporation
• Eureka Therapeutics
• firstVentury Equity
• Five Prime Therapeutics
• Credit Suisse Securities
• Dana-Farber Cancer Institute
• Deerfield Partners
• Onyx Pharmaceuticals
• Juno Therapeutics

Key Types

• Bispecific Antibodies
• Antibody Drug Conjugates
• Chimeric Antigen Receptor T-Cells

Key End-Use

• Liver Cancer
• Respiratory Cancer
• Brain Cancer
• Others

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaB-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Forecast
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast by Type
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2020E-2025F (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2025 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2020E-2025F (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2025 (Volume)
8.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast by End-Use (2020E-2025F)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2025 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast by Region (2020E-2025F)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by Region in 2025 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Transposagen Biopharmaceuticals
  9.1.1 Transposagen Biopharmaceuticals Profile
Table Transposagen Biopharmaceuticals Overview List
  9.1.2 Transposagen Biopharmaceuticals Products & Services
  9.1.3 Transposagen Biopharmaceuticals Company Dynamics & News
  9.1.4 Transposagen Biopharmaceuticals Business Operation Conditions
Table Business Operation of Transposagen Biopharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Sutro Biopharma
  9.2.1 Sutro Biopharma Profile
Table Sutro Biopharma Overview List
  9.2.2 Sutro Biopharma Products & Services
  9.2.3 Sutro Biopharma Company Dynamics & News
  9.2.4 Sutro Biopharma Business Operation Conditions
Table Business Operation of Sutro Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Malin Corporation
  9.3.1 Malin Corporation Profile
Table Malin Corporation Overview List
  9.3.2 Malin Corporation Products & Services
  9.3.3 Malin Corporation Company Dynamics & News
  9.3.4 Malin Corporation Business Operation Conditions
Table Business Operation of Malin Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Eureka Therapeutics
  9.4.1 Eureka Therapeutics Profile
Table Eureka Therapeutics Overview List
  9.4.2 Eureka Therapeutics Products & Services
  9.4.3 Eureka Therapeutics Company Dynamics & News
  9.4.4 Eureka Therapeutics Business Operation Conditions
Table Business Operation of Eureka Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 firstVentury Equity
  9.5.1 firstVentury Equity Profile
Table firstVentury Equity Overview List
  9.5.2 firstVentury Equity Products & Services
  9.5.3 firstVentury Equity Company Dynamics & News
  9.5.4 firstVentury Equity Business Operation Conditions
Table Business Operation of firstVentury Equity (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Five Prime Therapeutics
  9.6.1 Five Prime Therapeutics Profile
Table Five Prime Therapeutics Overview List
  9.6.2 Five Prime Therapeutics Products & Services
  9.6.3 Five Prime Therapeutics Company Dynamics & News
  9.6.4 Five Prime Therapeutics Business Operation Conditions
Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Credit Suisse Securities
  9.7.1 Credit Suisse Securities Profile
Table Credit Suisse Securities Overview List
  9.7.2 Credit Suisse Securities Products & Services
  9.7.3 Credit Suisse Securities Company Dynamics & News
  9.7.4 Credit Suisse Securities Business Operation Conditions
Table Business Operation of Credit Suisse Securities (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Dana-Farber Cancer Institute
  9.8.1 Dana-Farber Cancer Institute Profile
Table Dana-Farber Cancer Institute Overview List
  9.8.2 Dana-Farber Cancer Institute Products & Services
  9.8.3 Dana-Farber Cancer Institute Company Dynamics & News
  9.8.4 Dana-Farber Cancer Institute Business Operation Conditions
Table Business Operation of Dana-Farber Cancer Institute (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Deerfield Partners
  9.9.1 Deerfield Partners Profile
Table Deerfield Partners Overview List
  9.9.2 Deerfield Partners Products & Services
  9.9.3 Deerfield Partners Company Dynamics & News
  9.9.4 Deerfield Partners Business Operation Conditions
Table Business Operation of Deerfield Partners (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Onyx Pharmaceuticals
  9.10.1 Onyx Pharmaceuticals Profile
Table Onyx Pharmaceuticals Overview List
  9.10.2 Onyx Pharmaceuticals Products & Services
  9.10.3 Onyx Pharmaceuticals Company Dynamics & News
  9.10.4 Onyx Pharmaceuticals Business Operation Conditions
Table Business Operation of Onyx Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Juno Therapeutics
  9.11.1 Juno Therapeutics Profile
Table Juno Therapeutics Overview List
  9.11.2 Juno Therapeutics Products & Services
  9.11.3 Juno Therapeutics Company Dynamics & News
  9.11.4 Juno Therapeutics Business Operation Conditions
Table Business Operation of Juno Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume by Companies, 2015-2020E (Volume)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio in 2020E
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio in 2020E
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio in 2020E
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio in 2020E
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2015-2020 (Million USD)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2015-2020 (Volume)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2015-2020 (Million USD)
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2015-2020 (Volume)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type, 2020E-2025F (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume by Type, 2020E-2025F (Volume)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value by Region, 2020E-2025F (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume by Region, 2020E-2025F (Volume)
Table Transposagen Biopharmaceuticals Overview List
Table Business Operation of Transposagen Biopharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sutro Biopharma Overview List
Table Business Operation of Sutro Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Malin Corporation Overview List
Table Business Operation of Malin Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eureka Therapeutics Overview List
Table Business Operation of Eureka Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table firstVentury Equity Overview List
Table Business Operation of firstVentury Equity (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Five Prime Therapeutics Overview List
Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Credit Suisse Securities Overview List
Table Business Operation of Credit Suisse Securities (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dana-Farber Cancer Institute Overview List
Table Business Operation of Dana-Farber Cancer Institute (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Deerfield Partners Overview List
Table Business Operation of Deerfield Partners (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Onyx Pharmaceuticals Overview List
Table Business Operation of Onyx Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Juno Therapeutics Overview List
Table Business Operation of Juno Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume by Companies, 2015-2020E (Volume)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaB-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Figure America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2020 (Million USD)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2020 (Volume)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type in 2025 (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Volume Share by Type in 2025 (Volume)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Value Share by Region in 2025 (Million USD)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume Share by Region in 2025 (Volume)